c

Nice | Rivaroxaban for DVT treatment

21st August 2012 by Louise Hudman

This guideline advises that Rivaroxaban can now be considered for use in the treatment of proximal DVT. It is as effective as warfarin, but is more expensive. I suspect we will need to await local approval before use. It doesn’t require monitoring.

It is contraindicated with GFR < 30 and ‘very high blood pressure’ among other things. Use is normally for 3m, though may be needed for longer if there are ongoing risk factors for VTE. It hasn’t really been studied beyond 12m, so use beyond that is of uncertain effectiveness (though is allowed).

Interestingly, there is a higher risk of non-major bleeding with rivaroxaban than on warfarin, though a similar rate of major bleeding.

Read more

No credit card details needed – it takes two minutes.

Join free trial

Login

Already a member? Login to view this content.

Login

"I started using LocumDeck as one of our locums used it. It was easy to see her availability and when bookings are made I get confirmation of the booking and can view them on the calendar too. When invoices are sent, I can see it on the site, and digitally sign the pension form (this is one of the best bits!). I can access it from home or my mobile which is useful as when I am not in surgery is when I usually need a locum."

Debbie, Practice Manager, St Ives

See the full list of features within our NASGP membership plans

Membership